EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Statins for primary prevention in multimorbid patients: to prescribe or not to prescribe? A qualitative analysis of general practitioners’ decision-making processes

Racha Onaisi iD, Anaïs Bezzazi, Thomas Berthouin, Justine Boulet, Jennifer Hasselgard-Rowe iD, Hubert Maisonneuve iD

Family Practice · 2025

DOI: 10.1093/fampra/cmad068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Family Practice, 2025. Verfasst von Racha Onaisi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice, University of Bordeaux, F-33000 Bordeaux, France. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, General Practitioners, Primary Prevention, Practice Patterns, Physicians'. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Geneva.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

A better understanding of the determinants involved in general practitioners’ (GPs) decision-making processes when it comes to prescribing statins as primary prevention in patients with multimorbidity could provide insights for improving implementation of primary prevention guidelines.

Methods

We conducted a qualitative study using a deductive framework-based and inductive analysis of GPs’ semi-structured interviews verbatim, from which expertise profiles of prescribers were also drawn. The analytical framework was built from a pragmatic synthesis of the evidence-based medicine, Modelling using Typified Objects (MOT) model of clinical reasoning processes, Theoretical Domains Framework, and shared decision-making frameworks.

Results

Fifteen GPs were interviewed between June 2019 and January 2020. Diabetes seemed to represent a specific motivation for deciding about statin prescription for primary prevention purposes; and in situations of multimorbidity, GPs differentiated between cardiovascular and non-cardiovascular multimorbidity. Expert prescribers seemed to have integrated the utilisation of cardiovascular risk calculation scores throughout their practice, whereas non-expert prescribers considered them difficult to interpret and preferred using more of a “rule of thumb” process. One interviewee used the risk calculation score as a support for discussing statin prescription with the patient.

Conclusion

Our results shed light on the reasons why statins remain under-prescribed for primary prevention and why non-diabetic multimorbid patients have even lower odds of being prescribed a statin. They call for a change in the use of risk assessment scores, by placing them as decision aids, to support and improve personalised shared decision-making discussions as an efficient approach to improve the implementation of recommendations about statins for primary prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsGeneral PractitionersPrimary PreventionPractice Patterns, Physicians'Cardiovascular DiseasesClinical Decision-MakingHumansQualitative ResearchFemaleMaleMultimorbidityMiddle AgedInterviews as TopicDecision MakingAdult

Stichwörter der Autor:innen

cardiovascular preventionclinical reasoningdecision aiddecision makingshared decision makingstatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of General Practice, University of Bordeaux, F-33000 Bordeaux, France.
  • University College of General Medicine, University Claude Bernard Lyon 1, Lyon, France.
  • Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • University Institute for Primary Care, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

ORCID-Profile: Racha Onaisi, Jennifer Hasselgard-Rowe, Hubert Maisonneuve

Förderung

  • University of Geneva

Zitieren

APA

Onaisi, R., Bezzazi, A., Berthouin, T., Boulet, J., Hasselgard-Rowe, J., & Maisonneuve, H. (2025). Statins for primary prevention in multimorbid patients: to prescribe or not to prescribe? A qualitative analysis of general practitioners’ decision-making processes. Family Practice. https://doi.org/10.1093/fampra/cmad068

Vancouver

Onaisi R, Bezzazi A, Berthouin T, Boulet J, Hasselgard-Rowe J, Maisonneuve H. Statins for primary prevention in multimorbid patients: to prescribe or not to prescribe? A qualitative analysis of general practitioners’ decision-making processes. Family Practice. 2025. doi:10.1093/fampra/cmad068

BibTeX
@article{Onaisi2025,
  author = {Onaisi, Racha and Bezzazi, Anaïs and Berthouin, Thomas and Boulet, Justine and Hasselgard-Rowe, Jennifer and Maisonneuve, Hubert},
  title = {Statins for primary prevention in multimorbid patients: to prescribe or not to prescribe? A qualitative analysis of general practitioners’ decision-making processes},
  journal = {Family Practice},
  year = {2025},
  doi = {10.1093/fampra/cmad068}
}
Kostenlos starten →